OR2D2
geneOn this page
Also known as OR11-610hg27
Summary
OR2D2 (olfactory receptor family 2 subfamily D member 2, HGNC:8244) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 2D2 (Q9H210). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 120776 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_003700
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8244 |
| Approved symbol | OR2D2 |
| Name | olfactory receptor family 2 subfamily D member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR11-610, hg27 |
| Ensembl gene | ENSG00000166368 |
| Ensembl biotype | protein_coding |
| OMIM | 608494 |
| Entrez | 120776 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000299459
RefSeq mRNA: 1 — MANE Select: NM_003700
NM_003700
CCDS: CCDS31416
Canonical transcript exons
ENST00000299459 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004472049 | 6891574 | 6892500 |
Expression profiles
Bgee: expression breadth tissue_specific, 5 present calls, max score 49.87.
Top tissues by expression
111 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 49.87 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 42.37 | silver quality |
| colonic epithelium | UBERON:0000397 | 41.42 | gold quality |
| cortical plate | UBERON:0005343 | 40.65 | silver quality |
| right uterine tube | UBERON:0001302 | 38.92 | silver quality |
| bone marrow | UBERON:0002371 | 38.75 | gold quality |
| granulocyte | CL:0000094 | 37.07 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| tonsil | UBERON:0002372 | 35.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| liver | UBERON:0002107 | 31.04 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.84 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 30.73 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.40 | gold quality |
| lymph node | UBERON:0000029 | 29.15 | gold quality |
| uterine cervix | UBERON:0000002 | 28.61 | gold quality |
| leukocyte | CL:0000738 | 28.57 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 28.04 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.61 | gold quality |
| myometrium | UBERON:0001296 | 27.12 | gold quality |
| frontal cortex | UBERON:0001870 | 27.10 | gold quality |
| calcaneal tendon | UBERON:0003701 | 26.85 | gold quality |
| endometrium | UBERON:0001295 | 26.67 | gold quality |
| blood | UBERON:0000178 | 26.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.78 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2d2 | ENSMUSG00000060503 |
| mus_musculus | Or2d2b | ENSMUSG00000062987 |
| rattus_norvegicus | Or2d2b | ENSRNOG00000077558 |
| rattus_norvegicus | Or2d2 | ENSRNOG00000080946 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 2D2 — Q9H210 (reviewed: Q9H210)
Alternative names: HB2, Olfactory receptor 11-610, Olfactory receptor 2D1, Olfactory receptor OR11-88
All UniProt accessions (2): Q9H210, A0A126GVN9
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_003691* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (24 total): topological domain 8, transmembrane region 7, sequence variant 6, chain 1, glycosylation site 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H210-F1 | 87.31 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 18 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, WP_GPCRS_CLASS_A_RHODOPSINLIKE, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
206 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2D2 | TAS2R13 | Q9NYV9 | 506 |
| OR2D2 | TAS2R5 | Q9NYW4 | 474 |
| OR2D2 | TAS2R50 | P59544 | 474 |
| OR2D2 | LACTB | P83096 | 448 |
| OR2D2 | VN1R4 | Q7Z5H5 | 447 |
| OR2D2 | TAS2R10 | Q9NYW0 | 419 |
| OR2D2 | ZNF215 | Q9UL58 | 419 |
| OR2D2 | VN1R2 | Q8NFZ6 | 419 |
| OR2D2 | TAS2R14 | Q9NYV8 | 419 |
| OR2D2 | TAS2R4 | Q9NYW5 | 373 |
| OR2D2 | VN1R1 | Q9GZP7 | 359 |
| OR2D2 | KRT31 | Q15323 | 348 |
| OR2D2 | ZNF214 | Q9UL59 | 337 |
| OR2D2 | OAZ2 | O95190 | 335 |
| OR2D2 | CYB5RL | Q6IPT4 | 324 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A2R8YED5, O14581, O43749, O76099, O95221, P0C626, P0C7N1, P0C7N5, P0DN81, P23266, P23275, P30955, P47890, P58173, P58181, P59922, Q15617, Q15619, Q15622, Q60878, Q60881, Q60895, Q6IEU7, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N0Y5, Q8N146, Q8N162, Q8N628, Q8NG98, Q8NGA1, Q8NGC2, Q8NGE5, Q8NGF4, Q8NGF8, Q8NGG0, Q8NGG3, Q8NGG4, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
223 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:6891856:C:CT | acceptor_gain | 0.8500 |
| 11:6891631:CAGG:C | acceptor_gain | 0.7900 |
| 11:6891635:C:CC | acceptor_gain | 0.7700 |
| 11:6891666:C:CC | acceptor_gain | 0.7600 |
| 11:6892307:T:TC | acceptor_gain | 0.7000 |
| 11:6891664:CA:C | acceptor_gain | 0.6900 |
| 11:6891857:A:T | acceptor_gain | 0.6900 |
| 11:6891630:TCAGG:T | acceptor_gain | 0.6400 |
| 11:6891631:CAGGC:C | acceptor_gain | 0.6400 |
| 11:6891641:A:C | acceptor_gain | 0.6400 |
| 11:6891665:A:AC | acceptor_gain | 0.6400 |
| 11:6892180:A:T | acceptor_gain | 0.6400 |
| 11:6891637:A:C | acceptor_gain | 0.6300 |
| 11:6892378:T:TA | donor_gain | 0.6200 |
| 11:6891863:A:T | acceptor_gain | 0.6100 |
| 11:6891633:GGC:G | acceptor_loss | 0.6000 |
| 11:6891634:GC:G | acceptor_loss | 0.6000 |
| 11:6891635:C:CA | acceptor_loss | 0.6000 |
| 11:6891636:T:C | acceptor_loss | 0.6000 |
| 11:6891803:C:A | donor_gain | 0.5900 |
| 11:6891962:TC:T | acceptor_gain | 0.5900 |
| 11:6892179:C:CT | acceptor_gain | 0.5900 |
| 11:6891669:T:TC | acceptor_gain | 0.5800 |
| 11:6891862:C:CT | acceptor_gain | 0.5800 |
| 11:6891633:GG:G | acceptor_gain | 0.5700 |
| 11:6891834:C:CC | acceptor_gain | 0.5600 |
| 11:6891632:AGG:A | acceptor_gain | 0.5400 |
| 11:6891802:C:CA | donor_gain | 0.5400 |
| 11:6891641:A:AC | acceptor_gain | 0.5300 |
| 11:6891847:A:C | acceptor_gain | 0.5300 |
AlphaMissense
1989 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:6892465:G:C | F12L | 0.913 |
| 11:6892465:G:T | F12L | 0.913 |
| 11:6892467:A:G | F12L | 0.913 |
| 11:6891748:A:C | F251L | 0.857 |
| 11:6891748:A:T | F251L | 0.857 |
| 11:6891750:A:G | F251L | 0.857 |
| 11:6892048:A:C | S151R | 0.806 |
| 11:6892048:A:T | S151R | 0.806 |
| 11:6892050:T:G | S151R | 0.806 |
| 11:6891970:G:C | F177L | 0.785 |
| 11:6891970:G:T | F177L | 0.785 |
| 11:6891972:A:G | F177L | 0.785 |
| 11:6891634:G:C | S289R | 0.777 |
| 11:6891634:G:T | S289R | 0.777 |
| 11:6891636:T:G | S289R | 0.777 |
| 11:6892056:A:G | W149R | 0.765 |
| 11:6892056:A:T | W149R | 0.765 |
| 11:6892219:G:C | F94L | 0.765 |
| 11:6892219:G:T | F94L | 0.765 |
| 11:6892221:A:G | F94L | 0.765 |
| 11:6892136:C:G | R122P | 0.760 |
| 11:6891967:A:C | F178L | 0.737 |
| 11:6891967:A:T | F178L | 0.737 |
| 11:6891969:A:G | F178L | 0.737 |
| 11:6892466:A:G | F12S | 0.736 |
| 11:6891787:A:C | F238L | 0.732 |
| 11:6891787:A:T | F238L | 0.732 |
| 11:6891789:A:G | F238L | 0.732 |
| 11:6891793:C:A | K236N | 0.731 |
| 11:6891793:C:G | K236N | 0.731 |
dbSNP variants (sampled 300 via entrez): RS1000798176 (11:6894396 C>A,T), RS1001595515 (11:6893847 T>C), RS1004203642 (11:6892631 T>A,C), RS1004256617 (11:6892216 T>C), RS1005038888 (11:6893013 A>AG), RS1006641478 (11:6891647 G>T), RS1007820506 (11:6891279 C>T), RS1008231752 (11:6894340 C>T), RS1011811820 (11:6891318 T>C), RS1012854945 (11:6891990 T>G), RS1013901286 (11:6893071 C>A,T), RS1014154994 (11:6893771 C>T), RS1014627886 (11:6893043 C>T), RS1017405005 (11:6891302 T>C), RS1018818596 (11:6892403 C>G,T)
Disease associations
OMIM: gene MIM:608494 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004691_20 | Huntington’s disease progression | 2.000000e-06 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008336 | disease progression measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-palmitoylglycerol | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Huntington disease